Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Covid-19 Prevention and Treatment by Targeting Proteins: An Experience to Fight Emerging Diseases Publisher Pubmed



Zare H1 ; Farkhondeh T2 ; Bakherad H3 ; Sharifi H4 ; Shirzeyli MH5 ; Samarghandian S6 ; Ghasemi F7, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
  2. 2. Department of Toxicology and Pharmacology, School of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran
  3. 3. Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Molecular Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
  5. 5. Department of Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  6. 6. Healthy Ageing Research Centre, Neyshabur University of Medical Sciences, Neyshabur, Iran
  7. 7. Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
  8. 8. Department of Medical Biotechnology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Source: Current Molecular Medicine Published:2024


Abstract

The coronavirus disease 2019 (Covid-19) pandemic has been considered a major threat to human health. Effective therapeutic approaches are urgently required. Spike protein and the Angiotensin-converting enzyme 2 (ACE2) receptors have critical roles in SARS-CoV-2 infection. As a result, these two proteins are considered potential targets for the development of a wide variety of biotherapeutics and vaccines for controlling Covid-19. The fusion proteins have desirable medicinal properties, including high serum half-life, stability, and solubility in the body. Moreover, other Fc-fusion proteins used to treat other diseases have no known side effects. These Fc-fusion proteins are valuable biopharmaceuticals and have been proposed as therapeutic candidates for the treatment and prevention of Covid-19 owing to their potential therapeutic benefits. © 2024 Bentham Science Publishers.
Related Docs
View other Related Docs
1. Utilization of Sumo Tag and Freeze-Thawing Method for a High-Level Expression and Solubilization of Recombinant Human Angiotensin-Converting Enzyme 2 (Rhace2) Protein in E. Coli, Protein and Peptide Letters (2022)
2. In Silico Investigation of Critical Binding Pattern in Sars-Cov-2 Spike Protein With Angiotensin-Converting Enzyme 2, Scientific Reports (2021)
3. The Favorable Impacts of Silibinin Polyphenols As Adjunctive Therapy in Reducing the Complications of Covid-19: A Review of Research Evidence and Underlying Mechanisms, Biomedicine and Pharmacotherapy (2022)
4. Covid-19 and the Potential of Janus Family Kinase (Jak) Pathway Inhibition: A Novel Treatment Strategy, Frontiers in Medicine (2022)
5. Gastrointestinal and Kidney Manifestations in Sarscov and Sars-Cov-2 Infections: Role of Angiotensin-Converting Enzyme 2, Physiology and Pharmacology (Iran) (2021)
6. Rhabdomyolysis Secondary to Covid-19 Infection and Vaccination: A Review of Literature, Frontiers in Medicine (2024)
7. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
8. Coenzyme Q10 and Its Therapeutic Potencies Against Covid-19 and Other Similar Infections: A Molecular Review, Advanced Pharmaceutical Bulletin (2023)
Experts (# of related papers)
View all Related Experts
Hamid Bakherad (3)
Reza Nedaeinia (3)
Other Related Docs
9. Novel Sars-Cov2 Poly Epitope Phage-Based Candidate Vaccine and Its Immunogenicity, Research in Pharmaceutical Sciences (2024)
10. Hypotheses for Reactivation Recurrence and Reinfection Recurrence of Covid-19, Applied Biological Research (2021)
11. Comprehensive Overview of Covid-19-Related Respiratory Failure: Focus on Cellular Interactions, Cellular and Molecular Biology Letters (2022)
12. Screening of Potential Inhibitors of Covid-19 With Repurposing Approach Via Molecular Docking, Network Modeling Analysis in Health Informatics and Bioinformatics (2022)
13. Pi3k/Akt/Mtor Pathway: A Potential Target for Anti-Sars-Cov-2 Therapy, Immunologic Research (2022)
14. Mechanisms of Covid-19 Entry Into the Cell: Potential Therapeutic Approaches Based on Virus Entry Inhibition in Covid-19 Patients With Underlying Diseases, Iranian journal of allergy, asthma, and immunology (2021)
15. Antiviral Mechanisms of Curcumin and Its Derivatives in Prevention and Treatment of Covid-19: A Review, Advances in Experimental Medicine and Biology (2023)
16. Covid-19 Vaccines: Current and Future Challenges, Frontiers in Pharmacology (2024)
17. Exploring the Out of Sight Antigens of Sars-Cov-2 to Design a Candidate Multi-Epitope Vaccine by Utilizing Immunoinformatics Approaches, Vaccine (2020)
18. Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges, Applied Sciences (Switzerland) (2020)
19. Computational Design of a Potential Therapeutic Peptide Against Spike Protein of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
20. Using in Silico Bioinformatics Algorithms for the Accurate Prediction of the Impact of Spike Protein Mutations on the Pathogenicity, Stability, and Functionality of the Sars-Cov-2 Virus and Analysis of Potential Therapeutic Targets, Biochemical Genetics (2023)
21. Cardiovascular Complications of Sars-Cov-2 Vaccines: An Overview, Cardiology and Therapy (2022)
22. Herbal Medicines As Potential Inhibitors of Sars-Cov-2 Infection, Current Pharmaceutical Design (2022)
23. Genetics and Genomics of Sars-Cov-2: A Review of the Literature With the Special Focus on Genetic Diversity and Sars-Cov-2 Genome Detection, Genomics (2021)
24. Chitin and Chitosan As Tools to Combat Covid-19: A Triple Approach, International Journal of Biological Macromolecules (2021)
25. Outlook of Therapeutic and Diagnostic Competency of Nanobodies Against Sars-Cov-2: A Systematic Review, Analytical Biochemistry (2022)
26. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
27. Evaluation of Angiotensin Converting Enzyme 2 (Ace2), Angiotensin Ii (Ang Ii), Mir-141-3P, and Mir-421 Levels in Sars-Cov-2 Patients: A Case-Control Study, BMC Infectious Diseases (2024)
28. The Kinetics of Inhibitory Immune Checkpoints During and Post-Covid-19: The Knowns and Unknowns, Clinical and Experimental Medicine (2023)
29. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
30. Classification of Viral Proteins Expressed by the Sars-Cov-2 Genome, Acta Microbiologica Hellenica (2022)
31. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
32. Vaccine Production by Recognizing the Functional Mechanisms of Covid-19, Translational Research in Urology (2020)
33. Correlation of Expression of Mmp-2, Ace2, and Tmprss2 Genes With Lymphopenia for Mild and Severity of Covid-19, Iranian Journal of Allergy, Asthma and Immunology (2023)
34. Medicinal Chemistry of Antisense Oligonucleotides for Therapeutic Use in Sars-Cov-2: Design Strategies and Challenges for Targeted Delivery, Current medicinal chemistry (2025)
35. Human Microbiome in Post-Acute Covid-19 Syndrome (Pacs), Current Research in Microbial Sciences (2025)
36. The Role of Immune Regulatory Molecules in Covid-19, Viral Immunology (2022)
37. Different Aspects in Explaining How Mutations Could Affect the Binding Mechanism of Receptor Binding Domain of Sars-Cov-2 Spike Protein in Interaction With Ace2, PLoS ONE (2023)
38. Sars-Cov-2, Sars and Mers: Three Formidable Coronaviruses Which Have Originated From Bats; [Sars-Cov-2, Sars-Cov I Mers-Cov: Trzy Grozne Koronawirusy Pochodzace Od Nietoperzy], Postepy Higieny i Medycyny Doswiadczalnej (2021)
39. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
40. New Treatments (Msc) in Immune Disorders Like Cancers and Covid Infection: Cancer and Virus New Treatment (Msc), Asia Pacific Journal of Cancer Biology (2024)
41. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
42. Nanobodies, the Potent Agents to Detect and Treat the Coronavirus Infections: A Systematic Review, Molecular and Cellular Probes (2021)
43. Immunoinformatic Approach to the Design of a Novel Multi-Epitope Vaccine Against Leishmania Major Fused to Human Igg-Fc, Research in Pharmaceutical Sciences (2024)
44. Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (Ace2) Through Computational Approach, Journal of Medical Signals and Sensors (2022)
45. Mesenchymal Stem Cells: A Potent Cell Source for Covid-19, Coronaviruses (2021)
46. The Effect of Various Compounds on the Covid Mechanisms, From Chemical to Molecular Aspects, Biophysical Chemistry (2022)
47. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
48. Immune and Bioinformatics Identification of T Cell and B Cell Epitopes in the Protein Structure of Sars-Cov-2: A Systematic Review, International Immunopharmacology (2020)